Gsk (GSK) Goodwill & Intangibles (2009 - 2026)

Gsk's Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $32.4 billion for Q2 2026.

• In Q2 2026, Goodwill & Intangibles rose 10.0% year-over-year to $32.4 billion; the TTM figure through Jun 2026 stood at $32.4 billion (up 10.0% YoY), while the FY2025 annual figure was $31.3 billion, up 8.97% from the prior year.
• Goodwill & Intangibles for Q2 2026 stood at $32.4 billion, down from $34.3 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $37.2 billion in Q1 2022, with the low at $21.8 billion in Q2 2022.
• The 5-year median for Goodwill & Intangibles is $28.5 billion (2024), against an average of $29.0 billion.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles tumbled 60.86% in 2022, then gained 27.95% in 2023.
• Gsk's Goodwill & Intangibles stood at $25.1 billion in 2022, then rose by 6.88% to $26.8 billion in 2023, then rose by 7.81% to $28.9 billion in 2024, then increased by 9.48% to $31.6 billion in 2025, then rose by 2.64% to $32.4 billion in 2026.
• Business Quant data shows GSK's Goodwill & Intangibles at $32.4 billion in Q2 2026, $34.3 billion in Q1 2026, and $31.6 billion in Q4 2025.